ÂÜÀòÂÒÂ×

Stephane Dedieu's work experience includes roles at several organizations in the scientific and healthcare fields. Stephane is currently serving as the Co-founder and Chair of the Scientific and Clinical Advisory Board at Apmonia Therapeutics since April 2019. Prior to this, they were a member of the Scientific and Clinical Committee at Cancéropôle Est starting in 2018. From 2004 to the present, Stephane has been affiliated with Université de Reims Champagne-Ardenne, first as an Assistant Professor and Group Leader, and later as a Professor and Team Leader. Stephane has also been actively involved with CNRS, where they served as an Elected member of the National Committee for Scientific Research and as a Section board member. Additionally, Stephane has expertise within the Ligue contre le cancer, where they were an Appointed expert member of the Interregional Scientific Council. Stephane began their career in 2003 at INSERM as a Post-doctoral researcher.

Stephane Dedieu began their education at the Université de Bordeaux in 1994, where they completed their Bachelor's Degree in Cellular Biology and Physiology with a specialized area in Biochemistry and Molecular Biology in 1997. Stephane then pursued further studies at the same institution and obtained a Master's Degree in the Health-Biology area, graduating in 1999. Stephane continued their academic journey by enrolling in the Université de Bordeaux to pursue a Ph.D. in Biochemistry and Molecular Biology, which they successfully completed in 2003.